Intervention Review

Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma

  1. E. Haydn Walters1,*,
  2. Julia AE Walters2,
  3. Peter G Gibson3

Editorial Group: Cochrane Airways Group

Published Online: 22 JUL 2002

Assessed as up-to-date: 23 APR 2002

DOI: 10.1002/14651858.CD003901


How to Cite

Walters EH, Walters JAE, Gibson PG. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma. Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003901. DOI: 10.1002/14651858.CD003901.

Author Information

  1. 1

    University of Tasmania Medical School, Discipline of Medicine, Hobart, Tasmania, Australia

  2. 2

    University of Tasmania, Menzies Research Institute, Hobart, Tasmania, Australia

  3. 3

    John Hunter Hospital, Department of Respiratory and Sleep Medicine, Hunter Mail Centre, NSW, Australia

*E. Haydn Walters, Discipline of Medicine, University of Tasmania Medical School, 43, Collins Street, PO BOX 252-34, Hobart, Tasmania, 7001, Australia. Haydn.Walters@utas.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 JUL 2002

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stanley F. Malamed, Daniel L. Orr, Medical Emergencies in the Dental Office, 2015,

    CrossRef

  2. 2
    Christopher J Cates, Toby J Lasserson, Roman Jaeschke, Cochrane review: Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events, Evidence-Based Child Health: A Cochrane Review Journal, 2010, 5, 3
  3. 3
    Despina G. Contopoulos-Ioannidis, Maria S. Baltogianni, John P.A. Ioannidis, Comparative Effectiveness of Medical Interventions in Adults Versus Children, The Journal of Pediatrics, 2010, 157, 2, 322

    CrossRef

  4. 4
    Barbara Watts, Outpatient management of asthma in children age 5–11 years: Guidelines for practice, Journal of the American Academy of Nurse Practitioners, 2009, 21, 5
  5. 5
    Walter K. Kraft, Frank T. Leone, Pharmacology and Therapeutics, 2009,

    CrossRef

  6. 6
    Amy C. Plint, Kelly Russell, Candice L. Bjornson, Brian H. Rowe, The Cochrane Library and Long-Acting Beta-agonist Treatment for Childhood Asthma: An Overview of Reviews, Evidence-Based Child Health: A Cochrane Review Journal, 2008, 3, 4
  7. 7
    Nancy K. Ostrom, Outpatient Pharmacotherapy for Pediatric Asthma, The Journal of Pediatrics, 2006, 148, 1, 108

    CrossRef

  8. 8
    Xavier Flor, Isabel Álvarez, Eva Martín, Xavier Castan, Josep Maria Vigatà, Montserrat Rodríguez, Francesc Orfila, Eladi Fernández, Tratamiento del asma en atención primaria: ¿lo hacemos según el consenso internacional (GINA 2002)?, Atención Primaria, 2006, 38, 1, 19

    CrossRef

  9. 9
    Christopher J Cates, Toby J Lasserson, Regular fixed-dose treatment with formoterol and inhaled corticosteroids versus regular treatment with salmeterol and inhaled corticosteroids for chronic asthma: serious adverse events, The Cochrane Library,
  10. 10
    Christopher J Cates, Toby J Lasserson, Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events, The Cochrane Library,
  11. 11
    Christopher J Cates, Toby J Lasserson, Matthew J Cates, Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events, The Cochrane Library,
  12. 12
    Christopher J Cates, Roman Jaeschke, Stefanie Schmidt, Montse Ferrer, Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events, The Cochrane Library,
  13. 13
    Christopher J Cates, Toby J Lasserson, Roman Jaeschke, Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events, The Cochrane Library,
  14. 14
    Christopher J Cates, Matthew J Cates, Toby J Lasserson, Regular treatment with formoterol for chronic asthma: serious adverse events, The Cochrane Library,
  15. 15
    CJ Cates, MJ Cates, T Lasserson, Regular treatment with formoterol for chronic asthma: serious adverse events, The Cochrane Library,
  16. 16
    Christopher J Cates, Toby J Lasserson, Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events, The Cochrane Library,
  17. 17
    Christopher J Cates, Toby J Lasserson, Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events, The Cochrane Library,
  18. 18
    Christopher J Cates, Matthew J Cates, Toby J Lasserson, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events, The Cochrane Library,
  19. 19
    Christopher J Cates, Toby J Lasserson, Roman Jaeschke, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events, The Cochrane Library,
  20. 20
    Christopher J Cates, Roman Jaeschke, Stefanie Schmidt, Montse Ferrer, Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events, The Cochrane Library,
  21. 21
    Christopher J Cates, Matthew J Cates, Regular treatment with salmeterol for chronic asthma: serious adverse events, The Cochrane Library,
  22. 22
    CJ Cates, MJ Cates, Regular treatment with salmeterol for chronic asthma: serious adverse events, The Cochrane Library,